Skip to main content
Free trial

Ask AI to review this stock

Copy the prompt to get recent events, historical reactions, and a short research brief.

Tell your AI:

Help me set up FinLab and analyze 5314 世紀*. Please read: https://finlab.finance/en/setup?stock=5314

No install, open FinLab Studio

5314

世紀* Other As of 2026-06-17 Updated daily after market close

steady quality, discounted valuation.

2 active signals
Revenue ≥20% Foreign buy
This page refreshes daily after the close. Add 世紀* to your watchlist to track signal changes on your next visit.
Valuation 52Quality 72Growth 95Momentum 30Chips 17

Is 世紀* a buy? Fundamentals and valuation first

  • Above-average profitability.Operating margin is in the 66th market percentile. Latest quarterly ROE ≈ 4.0%.

  • Valuation is low.PE is in the 10th market percentile; within its own history, PE is around the 34th percentile.

  • Foreign investors are net selling.Foreign 20-day net flow ≈ -3.1% of volume (net sell).

  • Strong revenue growth.Latest monthly revenue YoY ≈ 157.4%, above the 20% growth threshold.

  • Signals are active now.On the latest data, signals such as Revenue YoY ≥ 20%, Foreign net buying 5 straight days are active — see the historical forward returns after each occurrence below.

Chip flow

Bearish -0.37
BearishNeutralBullish

Distribution to retail — bearish

  • Distribution to retail — bearish
  • 兆豐-中壢 holds 3,297 lots
  • sellers have 586 lots left, ~480 sessions to clear

Window from 2026-01-17 · Price -40% · branches to 2026-06-17· TDCC to 2026-06-12

  • Largest holder 兆豐-中壢 has accumulated 3,297 lots since the start (sold 0%), still adding.
  • Main distributor 新加坡商瑞銀 peaked at 2,475 lots, has sold 39%, 1,520 left, paused recently.
  • TDCC big holders (absolute) >1000-lot holders -4.01pp, mid holders -4, retail +4.56pp — drifting down to retail.
  • Foreign hedge-desk net short Net short -2,576 lots (inferred from branch profile, mostly hedging — not necessarily bearish, not case-confirmed).
Branch inventory reconstruction
Accumulating holders Branches that accumulated shares during the window and still hold positive inventory; they are the absorbing side.
Distributing sellers Branches that built inventory earlier and have been selling it down; the remaining number estimates what has not cleared.
Net-short desks Trading-desk branches with negative inventory or net selling, often hedge, offsetting, or short-term flow. It is not automatically a bearish view.
Accumulating
兆豐-中壢永豐金-台南華南永昌-潮州摩根大通兆豐-東門法銀巴黎
Distributing
新加坡商瑞銀凱基-台北港商野村統一永豐金-大園凱基
Desks
own scale
台灣摩根士丹利新光富邦證券國票-天祥
Price Accumulating & Distributing share one scale (comparable); Desks is independent. Zero is the baseline
Branch details Unit: lots

Accumulating

  • 兆豐-中壢 +3,297
    sold 0%· still adding
  • 永豐金-台南 +2,693
    sold 0%
  • 華南永昌-潮州 +749
    sold 0%· still adding
  • 摩根大通 +531
    sold 0%· still adding
  • 兆豐-東門 +358
    sold 0%· still adding
  • 法銀巴黎 +324
    sold 0%

Distributing

  • 新加坡商瑞銀 1,520 left
    sold 39%· paused recently
  • 凱基-台北 206 left
    sold 87%· paused recently
  • 港商野村 417 left
    sold 50%· paused recently
  • 統一 113 left
    sold 84%· ~8 sessions to clear
  • 永豐金-大園 204 left
    sold 32%· paused recently
  • 凱基 40 left
    sold 86%· ~16 sessions to clear

Desks

  • 台灣摩根士丹利 -1,797
    hedge desk · will cover
  • 新光 -1,416
    unclassified
  • 富邦證券 -1,393
    unclassified
  • 國票-天祥 -1,376
    unclassified
Still selling 586 lots ~480 sessions to bottom at most
Recent buy/sell force +1,587 absorbed / -419 sold buyers slightly ahead
Hedge-desk net short -1,874 lots potential cover-buying, not selling pressure
TDCC big holders · absolute-holding cross-check
>1000-lot holder share Retail (<400 lots) share Price (right axis)

Weak direction: big-holder share fell while retail share rose.

Describes chip flow, not investment advice. Branch data discloses only high-volume branches with ~1-day lag; TDCC is weekly. Inventory is a relative reconstruction from the window start, not absolute holdings.

Historical evidence

Signals active now

These signals are true on the latest data, with this stock's own historical forward-return stats after each occurrence.

Monthly revenue YoY ≥ 20% (from filing deadline)

Active · now 157.45%

Monthly revenue YoY ≥ 20%; event date is the first trading day after the filing deadline (no look-ahead).

74 historical occurrences (since 2007-04-23)
Average forward return after Monthly revenue YoY ≥ 20% (from filing deadline)。20-day: Win 59.1%, Sample 66, Median +2.45%, Excess +8.41%, Beat mkt rate 48.5%；60-day: Win 54.7%, Sample 64, Median +6.25%, Excess +33.03%, Beat mkt rate 56.2%；120-day: Win 59%, Sample 61, Median +9.64%, Excess +76.46%, Beat mkt rate 49.2%

120 days after: historical avg +90.06%

20-day +10.58%
60-day +39.41%
120-day +90.06%
20-day
60-day
120-day
Win
59.1%
54.7%
59%
Sample
66
64
61
Median
+2.45%
+6.25%
+9.64%
Excess
+8.41%
+33.03%
+76.46%
Beat mkt rate
48.5%
56.2%
49.2%

Over 61 occurrences, 120-day forward avg gained 90.06%, beat the market by 76.46 pts; win rate 59%.

Foreign net buying for 5 straight days

Active · now 5%

Foreign net flow (ex-dealer) positive for 5 straight days; event on day 5; repeats within 20 days counted once.

16 historical occurrences (since 2012-06-11)
Average forward return after Foreign net buying for 5 straight days。20-day: Win 53.3%, Sample 15, Median +5.94%, Excess +14.15%, Beat mkt rate 53.3%；60-day: Win 57.1%, Sample 14, Median +1.71%, Excess +61.73%, Beat mkt rate 50%；120-day: Win 53.8%, Sample 13, Median +29.19%, Excess +81.74%, Beat mkt rate 46.2%

120 days after: historical avg +92.45%

20-day +15.74%
60-day +66.44%
120-day +92.45%
20-day
60-day
120-day
Win
53.3%
57.1%
53.8%
Sample
15
14
13
Median
+5.94%
+1.71%
+29.19%
Excess
+14.15%
+61.73%
+81.74%
Beat mkt rate
53.3%
50%
46.2%

Over 13 occurrences, 120-day forward avg gained 92.45%, beat the market by 81.74 pts; win rate 53.8%.

Valuation regime and subsequent returns

Each day's PE is converted to its own-history percentile (as of that day), then we look at adjusted-close returns over the next 240 trading days by valuation regime.

PE percentile bandSample days240-day avg returnMedianWin rateAvg excess (vs index)
0-20 0Insufficient data
20-40 You are here2Insufficient data
40-60 164+851.4% +849.8% 100% +789.7%
60-80 155+388.5% +409% 99.4% +337.9%
80-100 127+218.1% +189.5% 99.2% +186.3%

Percentiles use an expanding own-history window (no look-ahead); forward return is 240 trading days on adjusted close. Sample days overlap; distribution is indicative only.

Current PE ≈ 11.03, at the 34.5th percentile of its own history (20-40 band).

Valuation × momentum historical grid

Every day in its own history is bucketed by valuation tercile (own-history PE) and 60-day momentum sign into six cells; we show adjusted-close returns over the next 120 trading days per cell.

Valuation
Momentum
Cheap (own-history bottom 1/3)
Mid
Expensive (own-history top 1/3)
60-day momentum up
Insufficient data
(0d)
+552.2%
Win rate 88% Excess +500.5%
158d
+62.6%
Win rate 64.2% Excess +40.2%
293d
60-day momentum down
Insufficient data
(0d)
Now
+325.1%
Win rate 96.3% Excess +308.3%
109d
Insufficient data
(3d)

Currently in “Mid × 60-day momentum down”: across 109 historical days, 120-day forward avg gained 325.1%, win rate 96.3%, beat the market by 308.3%.

Days = trading days in this bucket; returns use adjusted prices, ex-costs. 60-day momentum: direction of this stock's price over the past 60 trading days.

Does this signal hold up across the market

Over the past 242 months, on average ~404 stocks per month met “monthly revenue YoY ≥ 20%”; their adjusted-close return over the next 60 trading days averaged 6.94% (equal-weighted), beating the market by 2.37 points on average, and outperformed the TAIEX total-return index in 64.5% of months.

Each month, equal-weighted 60-day forward adjusted return of all signal-matching stocks, then averaged across months; excess vs the TAIEX total-return index.

Signals not active (historical stats for reference)

These are not occurring now; historical samples shown for comparison.

252-day price high (breakout)

Pending

Adjusted close makes a new 252-day high; repeats within 20 days counted once.

26 times historically; 60-day forward avg +26.44%, win rate 57.7%, beating the market by +21.95 pts on average.

What does 世紀* do? Company profile

其他；公司正由IC設計轉型至保健食品、AI智慧大健康、無人機與電商通路等多角化事業 櫃買中心上櫃

Overview

5314 為櫃買中心上櫃普通股，非ETF、ETN或權證。公司全名世紀民生科技股份有限公司，股票簡稱世紀*，英文常用名稱 Myson Century, Inc.。公司基本資料顯示成立時間為民國80年7月29日（1991-07-29），上櫃時間為民國85年9月16日（1996-09-16），總部位於台南市安平區永華路二段248號8樓之6。董事長為張祐銘，總經理與發言人為張碩文。公司網站揭露股本約1.47億元，櫃買中心揭露實收資本額為新台幣146,000,000元；部分金融資料庫顯示已發行普通股數292,000,000股，推估與每股面額調整有關，需以公開資訊觀測站最新股本資料為準。公司早期為MCU、視訊與通訊IC設計公司，2001年與世紀半導體合併並更名，2021年前後上曜建設開發取得經營權。主要股東方面，公開資料顯示上曜建設開發為重要法人股東與董事法人，另有信立化學工業、啟航投資、宋權宮、和瑞投資等歷史主要股東資料；2025年9月董監持股資料顯示上曜建設開發持股約17.2%。員工規模方面，104人力銀行揭露約180人，但112年年報曾揭露母公司員工12人；兩者口徑可能分別為集團/招募口徑與個體公司口徑。

Business

公司目前營運重心已由傳統IC設計擴展為多事業平台。依公司資料與法說簡報，主要產品與服務包括：一、保健食品與AI智慧大健康：透過旗下或合作品牌「朝和生醫」銷售健康美顏、健康睡眠、健康美體、外泌體相關保健食品，包括雪之肌覓、雪肌泌、維骨泌/維股泌晶凍、夢之淵等產品，主打30至65歲健康需求、銀髮照護與醫美術後保養等場景；公司並導入AI智能營養師、CRM、健康數據分析與會員推薦。二、電商與通路：透過官方網站、Facebook、LINE、IG、蝦皮、MOMO、東森購物、YouTube、TikTok、女人知己、抖音、直播電商、0800電話銷售與雲康世紀直銷通路擴大保健食品銷售；2025年收購松果購物後，強化D2C、會員數據與通路掌握。三、無人機與AI智能機器人：公司自2023至2024年起切入AI智能機器人與無人機市場，主張自研飛控電腦、GPS模組、通訊圖傳、電子變速器、電池模組與AI熱像多光譜影像系統，應用於巡檢、救災、物流、國防與低空經濟。四、保險經紀與數位金融：法說簡報稱將健康數據與保險服務結合，發展動態保費、健康管理與數位金融應用。五、其他歷史或過渡業務：包含裝修工程、餐飲、數位監控系統、商品買賣、廣告服務等。營收結構方面，113年年報揭露113年度銷貨收入約3.923億元、占總營收約62.45%，工程收入約1.223億元、占約19.47%，另有廣告服務收入約0.687億元；2025年與2026年營收結構因併購與轉型快速變動，公開資料多以保健食品、大健康、電商通路、無人機與保險經紀收入描述，未找到完整且經會計師查核的最新細項占比。

Outlook 2025–2028

2025至2028年展望可分為成長動能與風險兩面。成長動能：一、智慧大健康與保健食品。公司2025年營收大幅成長，公開新聞與法說資料揭露2025年合併營收約29.83億至30.59億元、年增約375%，2025年EPS約5.56至5.59元；數字差異可能來自自結、合併口徑或資料庫更新差異。2026年第一季合併營收約13億元，年增184%，EPS約0.37元；2026年5月單月營收約5.13億元，累計營收約22.89億元、年增約160.59%。二、鳳凰計畫2.0。公司表示2026年起由事業版圖快速擴張轉向既有數據、技術與流量資產變現，結合穿戴裝置、AI分析、營養保健、數位照護與保險服務，發展健康管理、風險預防與金融保障生態系。三、通路與併購。公司2025年起透過松果購物、詠昇電子、拓米生技、星雲電腦、崴浤科技、台保大保經等投資或併購布局，企圖建立從原料/CDMO、智慧製造、品牌、電商通路、會員數據到保險變現的一條龍。四、無人機與低空經濟。法說簡報指出台灣2025至2027年商規軍用無人機採購、非紅供應鏈、NDAA/Blue UAS趨勢、邊緣AI、自主飛控、EO/IR模組國產化，均可能成為無人機業務中長期題材；公司也提出USV無人船、UUV水下無人載具與空海一體化藍圖。主要風險與挑戰：一、轉型與併購整合風險高，2025年以來併購標的跨電商、生技、電子零組件、設備、保經與環保，若整合、內控、商譽或投資評價不如預期，獲利波動會放大。二、營收與EPS資料在不同來源間存在差異，且2025年EPS需留意每股面額調整後的可比性。三、保健食品與外泌體相關宣稱需受食品、廣告、醫療效能宣稱法規約束，若法規或消費者接受度變化，行銷效果可能受限。四、無人機國防訂單具高度不確定性，需經驗證、認證、採購程序、量產良率與交期考驗；公司簡報中的技術、採購與海外市場多屬展望或公司主張，尚需以實際訂單與財報貢獻驗證。五、電商、直播與保健食品競爭激烈，流量成本、代言行銷費、平台抽成、退貨率與庫存管理將影響毛利。六、關係企業交易、集團交叉持股與公開收購活動增加，投資人需關注關係人交易、公允價值變動與治理透明度。

Supply Chain

Upstream
  • 詠昇電子股份有限公司 6418 台股上櫃公司；世紀民生2025年公開資料稱曾基於財務性投資目的公開收購詠昇電子，法說簡報將其定位為電子零組件與醫療級連接器、穿戴裝置組件供應鏈能力。
  • 星雲電腦股份有限公司 8047 台股上櫃公司；公司法說資料與新聞稱投資/收購星雲可支援精密設備、無人機精密機構件、半導體設備製造與高階硬體開發。
  • 拓米生技股份有限公司 未確認為台股上市櫃公司；法說簡報將其列為高雄大寮智慧工廠與生技製造供應鏈骨幹，產品涵蓋醫療口罩、濕紙巾、寵物食品、長照用品等。
  • 世恆生技 未確認為台股上市櫃公司；法說簡報將其列為原料CDMO上游。
  • 愛沛公司 未確認為台股上市櫃公司；法說簡報將其列為沛能戒與艙體設備相關供應或事業單位。
  • STMicroelectronics等非中國電子元件供應鏈 非台股掛牌或未逐一揭露；公司簡報提到飛控電腦使用STM32F765等非陸製晶片，並主張無人機關鍵零組件非紅供應鏈。
  • 日本與德國專利保健原料供應商 未揭露具體公司或非台股掛牌；公司資料提到EOB686外泌體技術、神經醯胺、輔酶Q10、玄米胚芽、蠶絲蛋白等日本專利授權或高端原料。
Downstream
  • 松果購物 未確認為獨立台股上市櫃公司；世紀民生2025年收購創業家兄弟旗下松果購物，作為電商平台、會員數據與朝和生醫/沛能戒等產品通路。
  • 富邦媒體科技股份有限公司（momo） 8454 台股上市公司；公司簡報與網站列MOMO為保健食品與直播/電商銷售平台之一。
  • 雲康世紀股份有限公司 未確認為台股上市櫃公司；公司簡報稱世紀民生投資雲康世紀以拓展直銷傳播通路，擴大朝和生醫保健食品銷售。
  • 蝦皮購物 非台股上市櫃平台；公司簡報列為社群/電商銷售通路。
  • 東森購物 未確認為台股上市櫃公司；公司簡報列為電商與電視購物通路之一。
  • TikTok、YouTube、Facebook、LINE、IG、抖音等社群平台 多為海外或非台股掛牌平台；公司以直播、短影音、社群內容與KOL導購做為保健食品與大健康產品導流管道。
  • 台保大保險經紀人產業控股或保經通路 未確認為台股上市櫃公司；法說簡報稱其為保險經紀布局，未來可能承接健康數據、動態保費與數位金融應用。

Competitors

  • 大江生醫股份有限公司 8436 台股上櫃公司；保健食品、機能性食品、CDMO與生技保健領域競爭者。
  • 葡萄王生技股份有限公司 1707 台股上市公司；保健食品、益生菌、靈芝與生技食品品牌競爭者。
  • 大研生醫 未上市櫃品牌；MoneyDJ列為保健食品競爭者，與朝和生醫在保健品電商、品牌與行銷上競爭。
  • 雷虎科技股份有限公司 8033 台股上櫃公司；無人機、遙控模型、軍工與低空經濟題材競爭者。
  • 中強光電股份有限公司 5371 台股上櫃公司；MoneyDJ列為無人機競爭者，公司具光電、投影與無人機相關布局。
  • 經緯航太科技股份有限公司 興櫃公司，非上市櫃；無人機與航太服務競爭者，依規範stock_id填null。
  • 創業家兄弟股份有限公司 8477 台股上市公司；原為松果購物母集團，電商平台與網路零售領域可視為通路與電商競爭或合作對象。
Sources（18）

This company profile is compiled from public sources (annual reports, filings, news and analyst reports), not finlab backtest data; the 2025–2028 outlook contains forward-looking estimates and is for reference only.

Method and limitations

  • All returns use adjusted close (etl:adj_close), already adjusted for dividends and splits.
  • Excess return is measured against the TAIEX total-return index (dividends included).
  • Valuation regime and percentile stats use an expanding own-history window (no future data).
  • Revenue-signal event dates align to the first trading day after the filing deadline, avoiding look-ahead.
  • Event samples may overlap in time; stats describe historical distribution only and are less reliable when samples are few.

This page is historical statistics for educational purposes and is not investment advice. Investing involves risk; past performance does not indicate future results. Assess and bear the risk yourself before trading.